In 2024, MAB Robotics unveiled the Honey Badger, a quadruped robot demonstrated in footage to operate effectively underwater and on land. Its amphibious nature makes it versatile for applications like ...

“The non-dilutive nature of this financing facility supports balance sheet optionality so the company can focus on per-share value creation.” VYD2311 is a novel monoclonal antibody ...

Journalism, George Orwell reminded us, is publishing something that someone does not want printed. Everything else is PR.

CytoImmune Therapeutics, a pioneering biopharmaceutical company specializing in immunotherapy and monoclonal antibody (mAb) manufacturing, announced today its readiness to support pharmaceutical ...

Ghana is intensifying efforts to monitor and conserve its biodiversity resource as part of commitments to global ...

The Company reported a net loss of approximately $17.0 million, or a net loss per basic and diluted share of $1.39, for the ...

BOSTON and LONDON, May 01, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced ...

"We also observed an increase in symptomatic remission rates across groups in the OLE, with the 850 mg induction phase dose ...

You’re juggling bills, groceries, and school fees, and one month you dip below your bank’s minimum balance requirement. Next thing you know, your bank slaps you with a penalty.

The U.S. Food and Drug Administration (FDA) recently announced it plans to phase out animal testing in the development of monoclonal ...